BenzingaSeptember 18, 2026 at 8:21 AM NYLast Month
Morgan Stanley Maintains Overweight on Sempra, Lowers Price Target to $100
Morgan Stanley analyst David Arcaro maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $104 to $100.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
